Fair Brett 4
4 · Aclaris Therapeutics, Inc. · Filed May 9, 2018
Insider Transaction Report
Form 4
Fair Brett
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-05-07−4,050→ 3,038 total→ Common Stock (4,050 underlying) - Exercise/Conversion
Common Stock
2018-05-07+4,050→ 7,191 total - Tax Payment
Common Stock
2018-05-07$18.10/sh−1,153$20,869→ 6,038 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]On December 15, 2016, the reporting person was granted 8,100 restricted stock units. 50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone. The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.